This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2017-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2022
Title: Zhehong Cai: Innovator in Therapeutic Antibodies
Introduction
Zhehong Cai is a prominent inventor based in Sunnyvale, California. He has made significant contributions to the field of therapeutic antibodies, particularly in cancer treatment. With a total of three patents to his name, his work is recognized for its potential impact on medical science.
Latest Patents
Cai's latest patents focus on antibodies against OX-40 and their therapeutic applications. These patents detail antibodies that bind to OX-40, which are crucial in developing treatments for cancer. The patents also include information on the cells that produce these antibodies, as well as the polynucleotides encoding the heavy and light chain variable regions of the antibodies. This innovative work opens new avenues for cancer therapy.
Career Highlights
Zhehong Cai is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research in therapeutic applications. His expertise in antibody development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Cai collaborates with talented coworkers, including Indrani Chakraborty and Marie-Michelle Navarro Garcia. Together, they contribute to the innovative research environment at Bristol-Myers Squibb.
Conclusion
Zhehong Cai's work in developing antibodies against OX-40 showcases his commitment to advancing cancer treatment. His contributions to the field of therapeutic antibodies are invaluable and highlight the importance of innovation in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile